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Summary
b-catenin has been implicated in thymocyte develop-
ment because of its function as a coactivator of Tcf/
LEF-family transcription factors. Previously, we dis-
covered a novel pathway for p53-induced b-catenin
degradation through a ubiquitin E3 ligase complex in-
volving Siah1, SIP (CacyBP), Skp1, and Ebi. To gain in-
sights into the physiological relevance of this new
degradation pathway in vivo, we generated mutant
mice lacking SIP. We demonstrate here thatSIP2/2 thy-
mocytes have an impaired pre-TCR checkpoint with
failure of TCRb gene rearrangement and increased ap-
optosis, resulting in reduced cellularity of the thymus.
Moreover, the degradation of b-catenin in response to
DNA damage is significantly impaired in SIP2/2 cells.
SIP2/2 embryonic fibroblasts show a growth-rate in-
crease resulting from defects in G1 arrest. Thus, the
b-catenin degradation pathway mediated by SIP de-
fines an essential checkpoint for thymocyte develop-
ment and cell-cycle progression.
Introduction
b-catenin, an important regulator of cell-cell communi-
cation and embryonic development, associates with
and regulates the function of Tcf/LEF-family transcrip-
tion factors (Peifer and Polakis, 2000). Conditional deg-
radation of b-catenin represents a central event in Wnt
signaling pathways controlling cell fate and proliferation
(Peifer and Polakis, 2000). Interaction of Wnt-ligands
with frizzled-family receptors transduces signals that
suppressGSK3bactivity, viamechanisms requiringAPC,
Axin, and other proteins. Suppression of GSK3b reduces
phosphorylation of b-catenin, thus eliminating binding of
F box protein b-TrCP/Fbw1 and resulting in b-catenin
accumulation due to reduced ubiquitin-mediated prote-
olysis (Hart et al., 1999; Kitagawa et al., 1999b; Latres
et al., 1999; Winston et al., 1999). b-catenin accumulation
facilitates its translocation to a nucleus where it collabo-
rates with Tcf/LEF-family (high-mobility group) tran-
scription factors to activate expression of target genes
important for cell proliferation, such as c-myc (He et al.,
1998) and cyclin D1 (Tetsu and McCormick, 1999). Muta-
tions in b-catenin inappropriately activate various tran-
scription factors, thereby promoting malignant transfor-
mation (Peifer and Polakis, 2000; Polakis, 2000).
*Correspondence: smatsuzawa@burnham.orgGenotoxic stress triggers activation of checkpoints
that delay cell-cycle progression (Abraham, 2001;
Zhou and Elledge, 2000). Defective cell-cycle check-
points lead to genomic instability and a predisposition
to cancer. Cell-proliferation arrest is also required to al-
low T cell receptor (TCR) genes rearrangement in the
thymus, which is a crucial step in T cell development
(Borowski et al., 2002; Hoffman et al., 1996). This check-
point critically depends on stage-specific signals de-
rived from the thymic microenvironment. In this regard,
b-catenin has been implicated in T cell development,
where it plays an essential role in differentiation of
CD42CD82 double-negative to CD4+CD8+ double-
positive thymocytes (Ioannidis et al., 2001; Mulroy
et al., 2003; Xu et al., 2003). Moreover, expression of ac-
tive b-catenin in the thymus results in the generation of
T cells lacking mature T cell antigen receptors (TCRs)
and impairs thymocyte survival (Gounari et al., 2001).
Upon DNA damage, p53 is stabilized and activated via
posttranslational mechanisms, leading to growth arrest
or apoptosis (Hall and Lane, 1997; Hartwell and Kastan,
1994; Reed, 1996; Vogelstein et al., 2000). The p53 pro-
tein has been shown to transactivate a wide variety of
target genes, including the cell-cycle inhibitor p21waf-1
(El-Deiry et al., 1993; Harper et al., 1993). Upregulation
of p21waf-1 inhibits cyclin-dependent kinases, particu-
larly those that function during the G1 phase of the cell
cycle. However, waf-1-deficient mice develop normally,
and fibroblasts derived from p21waf-1-deficient mouse
embryos are only partially defective in their ability to
undergo cell-cycle arrest in response to DNA damage
(Brugarolas et al., 1995; Deng et al., 1995). These obser-
vations suggest the existence of an alternative p21waf-1-
independent pathway through which p53 can suppress
cell proliferation.
Previously, we and others observed that b-catenin is
downregulated by activated p53 (Liu et al., 2001; Matsu-
zawa and Reed, 2001; Sadot et al., 2001). Furthermore,
we discovered that this b-catenin degradation pathway
is mediated by a series of protein interactions involving
Siah1, SIP (CacyBP), Skp1, APC, and Ebi, an F box pro-
tein that binds b-catenin independently of the phosphor-
ylation sites recognized by b-TrCP/Fbw1 (Liu et al.,
2001; Matsuzawa and Reed, 2001). Siah family proteins
bind ubiquitin-conjugating enzymes and target proteins
for proteasome-mediated degradation (Reed and Ely,
2002). We identified a novel Siah-interacting protein
(SIP), an SGT1-related molecule that provides a physical
link between Siah-family proteins and the SCF ubiquitin
E3 ligase component Skp1 (Kitagawa et al., 1999a;
Matsuzawa et al., 2003; Santelli et al., 2005). Expression
of Siah1 is induced by p53 (Iwai et al., 2004; Matsuzawa
et al., 1998), thereby linking genotoxic injury to destruc-
tion of b-catenin, thus reducing activity of b-catenin-
binding Tcf/LEF transcription factors and contributing
to cell-cycle arrest (Matsuzawa and Reed, 2001).
To gain insights into the function of SIP in p53-in-
duced b-catenin degradation in vivo, we generated SIP
knockout mice. First, we identified a specific stage of
T cell development at which SIP is required for T cell
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30Figure 1. Targeted Disruption of Mouse SIP
Gene
(A) The targeting vector VICTR20, wild-type
SIP allele, and targeted allele are depicted.
The vector was targeted to the first intron of
the SIP locus. The closed rectangles denote
exons 1 and 2 of SIP, and the open rectangles
denote the retroviral LTRs.
(B) PCR analysis of genomic DNA extracted
from mouse tails. Primers were designed to
amplify the regions of wild-type and mutant
alleles. PCR products of wild-type (WT) and
mutated (KO) alleles are shown. The geno-
types of mice are presented above the lane.
(C) Immunoblot analysis of extracts from
SIP2/2, SIP+/2, and SIP+/+ mouse embryonic
fibroblasts (MEFs). Whole-cell lysates of
MEFs were prepared from the indicated
mouse genotypes and subjected to SDS-
PAGE and immunoblotting with rabbit anti-
SIP antibody and then reprobed with goat
anti-Hsc70 antibody. Bands corresponding
to SIP and Hsc70 are indicated. Asterisk indi-
cates nonspecific bands.
(D) Southern-blot analysis of genomic DNA
extracted from MEFs of the indicated SIP
genotypes. The DNA was digested with XbaI
and subjected to hybridization with the probe
shown in (A). The expected sizes of the bands
corresponding to WT and KO alleles are indi-
cated.
(E) Northern-blot analysis of total RNA iso-
lated from MEFs of the indicated SIP geno-
types. Hybridization was performed with
mouse SIP and GAPDH cDNA probes.differentiation, mimicking the previously reported effect
of constitutive expression of b-catenin in thymocytes.
Second, we show that embryonic fibroblasts derived
from mice lacking SIP are deficient in their ability to
arrest in G1 following DNA damage. These data under-
line the essential role of SIP as a component of the p53-
regulated pathway that controls b-catenin levels in vivo
and regulates the thymocyte development and G1 cell-
cycle checkpoint.
Results
Generation of SIP-Deficient Mice
The murine ortholog of SIP was initially characterized as
a calcyclin-binding protein (CacyBP) (Filipek and Kuz-
nicki, 1998; Filipek and Wojda, 1996) and resides on
chromosome 1H1. By searching the Omni Bank data-
base (http://www.lexgen.com) of ES cell clones with ret-
rovirus insertions, we identified a clone containing a ret-
roviral integration in the first intron of mouse SIP
(Figure 1A). A polymerase chain reaction (PCR) was es-
tablished for distinguishing the intact and targeted SIP
genes (Figure 1B). Using these ES cells, we obtained
mice carrying the disrupted SIP gene and observed
that homozygous SIP knockout mice are born with nor-
mal Mendelian ratios, indicating thatSIP is not an essen-
tial gene. SIP2/2mice grow normally and do not develop
spontaneous malignancies or other diseases. Mouse
embryonic fibroblasts (MEFs) were derived from day
14.5 (E14.5) SIP+/+, SIP+/2, and SIP2/2 embryos andanalyzed by immunoblotting to determine the levels of
SIP expression. Whole-cell lysates from MEFs showed
detectable amounts of SIP protein in SIP+/+ and SIP+/2
mice, but not in SIP2/2 mice. SIP protein levels were
lower in SIP+/2 than in SIP+/+ mice, indicating a dose-de-
pendent expression of both SIP alleles (Figure 1C). DNA
and RNA isolated from MEFs were analyzed by Southern
and northern blotting, respectively, with 32P-labeled
mSIP cDNA probes, confirming disruption of the SIP
gene and loss of SIP mRNA expression in SIP2/2 cells
(Figures 1D and 1E).
Smaller Thymus and Spleen Size
in SIP-Deficient Mice
SIP2/2 mice were fertile and grew normally during 18
months of observation. However, we noticed that
SIP2/2 mice have smaller thymus and spleen size than
wild-type mice (Figure 2A). Indeed, 4-week-old SIP2/2
mice have thymi and spleens that havew50% the cellu-
larity of organs from wild-type littermates (Figure 2B).
This difference in cellularity was not as prominent in 8-
month-old SIP2/2 mice, which have w85% of the cells
in the thymus and spleen in comparison to wild-type lit-
termates. This phenotype is similar to that of mice ex-
pressing stabilized b-catenin in the thymus (Gounari
et al., 2001). Histological analysis of the thymus glands
of SIP2/2 mice showed slightly smaller medullas com-
pared to SIP+/+ mice (Figure 2C). Also, in the spleen,
the size of the T and B areas were reduced in SIP2/2
mice (Figures 2D–2F), although the splenic structure
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31Figure 2. Size and Cellularity of Thymus and
Spleen Are Reduced in SIP-Deficient Mice
(A) Photographs of thymi and spleens from 4-
week-old wild-type and SIP2/2 mice.
(B) Total cell numbers contained in whole
thymi or spleens from 4-week-old wild-type
(n = 8) and SIP2/2 mice (n = 7) are shown.
(C–F) SIP+/+ and SIP2/2 mice at 4 weeks of
age were sacrificed, and histological analy-
ses were performed. Representative exam-
ples are shown: (C) H&E analysis of thymus,
(D) H&E analysis of spleens, (E) anti-Thy-1
staining of spleens, and (F) anti-B220 staining
of spleens.appeared normal (Figure 2B), thus suggesting a role for
SIP in B and T lymphocytes homeostasis.
Pre-TCR Checkpoint Is Impaired
in SIP-Deficient Thymocytes
Thymocytes develop from a double-negative (DN) stage
lacking expression of CD4 and CD8 to a double-positive
stage (DP), and they then mature to single-positive (SP)
T cells expressing either CD4 or CD8 and displaying sur-
face abTCR expression (Figure 3A). The DN stage can
be further divided into four successive developmental
stages identified by the differential expression of CD44
and CD25 on the surface of DN thymocytes: DN1
(CD44+CD25+), DN2 (CD44+CD252), DN3 (CD442CD25+),
and DN4 (CD442CD252). TCRb gene rearrangements
occur at the DN3 stage, resulting in the expression of a
pre-TCR (receptor complexes of TCRb, pTa, and CD3
chains lacking the TCR a-chain). The signals provided
by the pre-TCR together with other signals provided
by the thymic microenvironment, such as Wnt signaling,
support the transition of DN cells to the DP stage. Thy-
mocytes without pre-TCR signaling undergo cell-cycle
arrest and apoptosis, defining the pre-TCR checkpoint
(Wu and Strasser, 2001). Furthermore, p53 plays an im-
portant role in the pre-TCR checkpoint (Bogue et al.,
1996; Guidos et al., 1996; Haks et al., 1999; Jiang et al.,
1996).
To examine whether SIP-dependent b-catenin degra-
dation is required for the pre-TCR checkpoint, we per-
formed flow-cytometry analyses of thymocytes from4-week-old wild-type and SIP2/2 mice. Whereas both
SIP2/2 and wild-type mice have similar percentages of
DP and CD4 and CD8 single-positive T cell populations
(Figure 3B), the analysis of the DN population showed an
accumulation of the DN3 population in SIP2/2 mice
(Figure 3B). Also, among the thymocytes that did man-
age to progress to the DN4 stage in SIP2/2 mice, intra-
cellular TCRb expression was reduced, compared to
wild-type mice (Figure 3C), similar to observations previ-
ously made for mice in which stabilized b-catenin was
expressed in thymus (Gounari et al., 2001).
To further confirm that SIP2/2 thymocytes are able to
develop from DN3 to DN4 stage in the absence of TCRb
gene rearrangement, we measured catalytic activity of
recombinase in SIP2/2 thymocytes. Recombination-
activating genes RAG1 and RAG2 are essential for the
first step of V(D)J recombination in TCR gene rearrange-
ment. Mice lacking either of these genes are unable to
undergo V(D)J recombination, causing a complete block
of thymocyte differentiation at the pre-TCR checkpoint
(Mombaerts et al., 1992; Shinkai et al., 1992). To mea-
sure recombinase activity, we used a retroviral vector
that contains the 12- and 23-recombination signal
sequences (RSS), separated by a reverse EGFP cDNA
relative to 50LTR (Figure 3D). The retroviral vector inte-
grates into the host genome, whereas the LTR induces
bicistronic transcripts that allow for the simultaneous
assessment of recombination resulting in inversion of
the GFP cassette and GFP expression (Liang et al.,
2002). As shown in Figure 3E, recombinase activity
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32Figure 3. Impaired pre-TCR Checkpoint and
Increased Apoptosis in SIP-Deficient Thymo-
cytes
(A) T cell differentiation in the thymus. Repre-
sentative receptors and transcription factors
that are critical for the different transition
stages are indicated. DN denotes double-
negative, DP denotes double-positive, and
SP denotes single-positive T cells.
(B) SIP+/+ and SIP2/2 thymocytes were
stained with antibodies to CD4, CD8, TCRgd,
DX5, B220 (lineage marker, Lin), CD25, and
CD44. At left: CD4 and CD8 expression of
the total thymocyte population. At right:
CD44 and CD25 expression (gated in Lin-
cells). The percentages of cells in each quad-
rant are shown. Data are representative of six
experiments.
(C) Intracellular TCRb expression was ana-
lyzed in DN3 (CD442CD25+) and DN4
(CD442CD252) thymocytes from SIP+/+ and
SIP2/2mice. Left panel shows representative
data (n = 6). The right panel shows mean 6
standard error of the mean (SEM) for six
experiments, indicating percentage of DN4
thymocytes without TCRb intracellular stain-
ing. The difference in percentage of TCRb-
negative DN4 cells is statistically significant
(unpaired t test, p < 0.0009).
(D) Schematic representation of the retroviral
12/23 rEGFP vector for functional analysis of
RAG recombinase activity in thymocytes. The
construct contains a reverse EGFP reporter
(rEGFP) oriented between 12 (open triangle)
and 23 (closed triangle) RSS (Recombination
Signal Sequence). The rEGFP reporter is in-
verted to the sense orientation by RAG re-
combinase activity (Liang et al., 2002).
(E) Thymocytes were infected with the retro-
viral 12/23 rEGFP vector for 48 hr. Cells
were then stained with antibodies to Lin,
CD25, and CD44. GFP-positive cells were an-
alyzed in DN3 and DN4 thymocytes from
SIP+/+ and SIP2/2 mice. Representative data shows DN3 and DN4 thymocytes, showing GFP fluorescence. Numbers show mean 6 SEM
percentage of GFP-positive thymocytes for six experiments. The difference in percentage of GFP-positive DN4 cells is statistically significant
(unpaired t test, p < 0.0009).was significantly reduced in SIP2/2 DN4 cells compared
with wild-type cells, but not in DN3 cells. Thus, the
absence of SIP allows thymocytes to progress to the
DN4 stage despite absence of recombinase activity, in-
dicating that these SIP-deficient cells defy a checkpoint
in thymic development, akin to observations from mice
with constitutive expression of b-catenin in thymocytes
(Gounari et al., 2001).
Accumulation of b-catenin Protein and Increased
Apoptosis in SIP-Deficient Thymocytes
To confirm that SIP deficiency results in elevated b-cat-
enin expression in the developing thymus, we isolated
DN cells by cell sorting and compared b-catenin levels
in wild-type and mutant mice. DN thymocytes were frac-
tionated into Triton X-100-soluble and -insoluble frac-
tions to distinguish cytosolic versus nuclear b-catenin
(Sadot et al., 2000, Sadot et al., 2001). As shown in Fig-
ure 4A, the level of b-catenin in SIP2/2 DN cells was re-
markably increased in both the Triton X-100-soluble and
-insoluble fractions compared to wild-type thymocytes.
To analyze the b-catenin levels in thymocytes morequantitatively, we evaluated intracellular b-catenin im-
munostaining by flow cytometry and combined it with
surface staining for CD4, CD8, CD25, and CD44 antigens
(Figure 4B). Increased accumulation of b-catenin protein
was observed inSIP2/2DN3 cells compared to wild-type
DN3 cells, and to a lesser extent in DN4 thymocytes.
Altogether, these results suggest that SIP-deficient
thymocytes reach the DN3 stage of thymic develop-
ment, then either fail to complete differentiation or die.
Because SIP2/2mice showed reduced thymic cellularity
compared to wild-type mice, we hypothesized that im-
mature SIP2/2 thymocytes undergo apoptosis after dis-
obeying the pre-TCR checkpoint. To examine this possi-
bility, we analyzed the survival of thymocytes in culture
by Annexin V staining. Apoptotic cells were increased
among the DN4 (1.4-fold) and the DP (1.8-fold) popula-
tions in SIP2/2 thymocytes (Figure 4C), suggesting
that SIP deficiency increases apoptosis of developing
thymocytes at these stages of development in a manner
similar to what has been reported in mice with constitu-
tive expression of b-catenin in thymocytes (Gounari
et al., 2001). In contrast, the frequency of apoptotic cells
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33Figure 4. Increased Protein b-Catenin Levels
and Apoptosis in SIP-Deficient Thymocytes
(A) SIP+/+ and SIP2/2 thymocytes (1 3 109)
were stained with antibodies to CD4, CD8,
TCRgd, DX5, and B220 (Lin). Lin-negative thy-
mocytes were purified by cell sorting, and
equal amounts of Triton X-100-soluble (cyto-
solic) and Triton X-100-insoluble (nuclear
fractions) material from DN thymocytes
(20 mg/lane) were analyzed by immunoblot-
ting with anti-b-catenin and anti-SIP anti-
bodies. The membranes were reprobed with
antibodies to a-tubulin (cytosolic markers)
and PARP (nuclear markers).
(B) Thymocytes were stained with antibodies
to Lin, CD44, and CD25. Cells were then per-
meabilized and stained with anti-b-catenin-
fluorescein isothiocyanate antibody. Intracel-
lular b-catenin expression was analyzed in
DN3 and DN4 thymocytes from SIP+/+ and
SIP2/2mice. Data are representative of six in-
dependent experiments.
(C) Thymocytes were cultured for 24 hr and
then stained with antibodies to Lin (CD4,
CD8, TCRgd, DX5, and B220), CD44, CD25,
and Annexin V. The left panel shows repre-
sentative data for Annexin V staining results
for DN4 and DP thymocytes. The right panel
shows mean 6 SEM for % Annexin-V-posi-
tive thymocytes at the DN4 and DP stages
(n = 6). The increased percentage of An-
nexin-V-positive for SIP2/2 thymocytes at
the DN4 (p < 0.007) and DP (p < 0.004) stage
is statistically significant (unpaired t test).was not increased within the DN3 population (data not
shown). These data suggest that by disobeying the
pre-TCR checkpoint, SIP2/2 thymocytes inappropri-
ately proceed from the DN3 to DN4 and DP stage, result-
ing in reduced survival.
SIP-Deficient Cells Show Impaired b-Catenin
Degradation and Defective G1 Cell-Cycle
Checkpoint After g Irradiation and UV Irradiation
p53 plays an important role in the G1 cell-cycle check-
point induced by ionizing radiation (Kastan et al., 1992;
Wahl and Carr, 2001). MEFs provide an ideal cell model
system for studying p53-mediated G1 arrest (Attardi
et al., 2004). For example, wild-type MEFs treated with
g irradiation undergo p53-dependent G1 arrest, whereas
p532/2 MEFs fail to arrest (Kastan et al., 1992). For ex-
ploring the role of SIP in the G1 checkpoint induced
by DNA damage, early-passage MEFs from SIP+/+ and
SIP2/2 embryos were subjected to g irradiation (20 Gy),
and the percentage of cells entering S phase was deter-
mined 24 hr later (Figure 5A). Prior to g irradiation,SIP2/2
MEFs entered S phase more rapidly than wild-type
MEFs upon serum addition, but less than p532/2 MEFs.
After 20 Gy g irradiation, S phase entry by wild-typeMEFs was markedly suppressed. In contrast, p532/2
MEFs underwent S phase progression regardless of g
irradiation. SIP2/2 cells displayed a phenotype interme-
diate between wild-type and p532/2 MEFs (Figure 5A).
This phenotype of SIP2/2 cells is quite similar to MEFs
from p212/2 mice (Deng et al., 1995). These results sug-
gest that SIP is partially required for the G1-phase check-
point induced by g irradiation.
Next, we examined levels of endogenous b-catenin
protein by immunoblotting. As expected, g irradiation
triggered a decline in b-catenin levels in SIP+/+ MEFs.
In contrast, SIP2/2 and p532/2 MEFs failed to downre-
gulate b-catenin in response to g irradiation (Figure 5B).
In addition to the G1 checkpoint, p53 is also known to
control the mitotic spindle checkpoint (Cross et al.,
1995). To examine whether SIP also has a role in mitotic
spindle-checkpoint regulation, we compared the induc-
tion of polyploidy by nocodazole in wild-type, SIP2/2,
and p532/2 MEFs. Nocodazole-treated SIP+/+ MEFs ar-
rested with 4N DNA content (Figure 5C). In contrast,
p532/2 MEFs failed to arrest, proceeding through cell
cycle to become polyploid. Cells lacking SIP showed
an intact mitotic checkpoint, thus indicating that SIP is
not required for the mitotic spindle checkpoint.
Immunity
34Figure 5. SIP Deficiency Impairs b-Catenin
Degradation and G1 Cell-Cycle Arrest after
g Irradiation
(A) Serum-starved MEFs were released into
complete media containing BrdU (65 mM)
with no treatment or 20 Gy g irradiation. After
24 hr, cells were harvested and analyzed by
flow cytometry. Boxes labeled 1, 2, and 3 in-
dicate G0/G1, S, and G2/M phase cells, re-
spectively. The percentage of cells in each
phase of the cell cycle is shown in each dia-
gram.
(B) Serum-starved MEFs (96 hr) derived from
wild-type (WT),SIP2/2, and p532/2mice were
released into complete media with no treat-
ment or 20 Gy g irradiation. After 24 hr, cyto-
solic fractions were analyzed by immunoblot-
ting. All the membranes were reprobed with
goat anti-Hsc70 antibody as a control.
(C) Asynchronous wild-type (WT), SIP2/2,
and p532/2 MEFs were incubated in the ab-
sence or presence of 125 ng/ml nocodazole
for 24 hr. Cells were harvested and their DNA
contents were determined by FACS after
DNA staining with propidium iodide. DNA-
content FACS histograms are shown, as are
the positions of peaks for cells with 2N, 4N,
and 8N DNA content. Each of these experi-
ments was repeated three times with similar
results.Having observed that SIP is required for b-catenin
degradation and G1 arrest following g irradiation, we
next examined the effects of SIP deficiency in response
to UV irradiation, which we have described induces
Siah1 expression and b-catenin degradation (Iwai et al.,
2004; Matsuzawa et al., 1998). For these experiments,
early-passage MEFs were prepared from SIP+/+, and
SIP2/2 embryos and subjected to UV irradiation, and
then the number of viable cells was counted at various
times thereafter. Low-dose UV irradiation (10–20 J/m2)
induced proliferation arrest of wild-type (WT) MEFs with-
out inducing substantial apoptosis, whereas SIP2/2
MEFs continued to proliferate at nearly normal rates
(data not shown). UV irradiation triggered a decline in en-
dogenous b-catenin protein levels in MEFs from SIP+/+
(Figure 6A) andSIP+/2mice (data not shown). In contrast,
SIP2/2 MEFs failed to downregulate b-catenin (Fig-
ure 6A). Similarly, b-catenin levels were not reduced
in UV-irradiated p532/2 MEF cells, consistent with the
hypothesis that p53 and SIP operate in the same b-
catenin degradation pathway. A similar result was ob-
tained with splenocytes fromSIP2/2mice (Figure 6B). In-
terestingly, the basal levels of endogeneous b-catenin
protein were higher in SIP2/2 lymphocytes than in SIP+/+and SIP+/2 cells, further supporting a role for SIP in reg-
ulating endogenous b-catenin expression.
SIP-Deficient MEFs Show Enhanced
Proliferative Properties
Using early-passage MEFs from SIP+/+, SIP+/2, and
SIP2/2 embryos, we compared the proliferative proper-
ties of cells with different levels of SIP. At low passage
(e.g., passage 3), growth rates of MEFs from SIP2/2 em-
bryos were higher than MEFs from SIP+/+ and SIP+/2
embryos. All MEFs showed contact inhibition, but
the monolayers formed by SIP2/2 MEFs were more
crowded than those formed by SIP+/+ and SIP+/2. In
addition, the saturation densities of SIP2/2 MEFs were
significantly higher than those of wild-type and SIP+/2
MEFs (Figure 7A). At later passage (e.g., passage 7), pro-
liferation of SIP+/+ and SIP+/2 MEFs was significantly
reduced, whereas the proliferation of SIP2/2 MEFs re-
mained robust (Figure 7A).
Activation of Tcf/LEF-family transcription factors by
b-catenin is known to induce expression of cyclin D1,
c-myc, and other genes important for cell proliferation
(He et al., 1998; Tetsu and McCormick, 1999). To further
examine the role of SIP in cell-cycle progression, we
SIP Regulates Thymocyte Development
35Figure 6. SIP Deficiency Impairs UV-Induced
b-Catenin Degradation and Cell-Cycle Arrest
(A) MEFs derived from wild-type (WT),SIP2/2,
and p532/2 mice were cultured for 24 hr prior
exposure to 20 J/m2 UV irradiation. After 24 or
48 hr, cytosolic fractions were analyzed by im-
munoblotting. The membrane was reprobed
with goat anti-Hsc70 antibody as a control.
(B) Splenocytes derived from SIP2/2, SIP+/+,
and SIP+/2 mice were cultured for 24 hr with
(+) or without (2) prior exposure to 10 J/m2
UV irradiation. Cytosolic fractions were pre-
pared from control or UV-irradiated cells
(after 24 hr) and aliquots (20mg) were analyzed
by immunoblotting, with antibodies specific
for b-catenin. The membrane was reprobed
with goat anti-Hsc70 antibody as a control.analyzed the expression of b-catenin target genes by
using serum-starved wild-type, SIP2/2, and p532/2
MEFs. After serum starvation, cells were cultured in
complete media and harvested 3 hr and 9 hr later, re-
spectively, and the levels of induction of Cyclin D1 and
c-Myc were compared. As shown in Figure 7B, SIP2/2
MEFs showed faster and higher induction of Cyclin D1
and c-Myc protein expression than wild-type MEFs,
similar to what is observed in p532/2 MEFs. These
data are consistent with previous reports describinga role for b-catenin as a transcriptional regulator of
cyclin D1 and c-myc genes (He et al., 1998; Tetsu and
McCormick, 1999).
Discussion
In this study, we showed that SIP-deficient embryonic
fibroblasts have a faster growth rate and express cyclin
D1 and c-myc at increased levels in comparison to wild-
type MEFs. We also show that these cells are partiallyFigure 7. SIP Deficiency Enhances Prolifera-
tion of MEFs
(A) Growth analysis of MEFs were performed
at passage 3 (early passage) and passage 7
(late passage). Cells (5 3 106) from SIP+/+,
SIP+/2, and SIP2/2 mice (as indicated in fig-
ures) were seeded into 60 mm dishes, and
cell numbers were counted at various times.
Representative data from three indepen-
dents experiments are shown.
(B) Serum-starved MEFs (96 hr) derived from
wild-type (WT),SIP2/2, and p532/2mice were
released into complete media. At 3 and 9 hr
after release, whole-cell lysates of MEFs
were subjected to SDS-PAGE immunoblot-
ting with anti-Cyclin D1, anti-c-Myc and
anti-Hsc70 antibodies.
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damage. SIP-deficiency also inhibits b-catenin downre-
gulation induced by p53-activating stimuli. p21waf-1 is
a well-known G1 cell-cycle inhibitor induced by p53.
However, p212/2 MEFs show only a partial defect in
the G1 cell-cycle checkpoint in response to DNA dam-
age, suggesting the existence of other p53-
dependent G1 checkpoint pathways. Taken together
with previous results, these observations demonstrate
that SIP is required for this alternative p53-dependent
G1 checkpoint. Although a G1-checkpoint failure may
lead to cancer, it is interesting to note that neither
p212/2 nor SIP2/2 mice develop spontaneous tumors,
suggesting that combined deficiency of p21 and SIP
may be necessary for tumorigenesis.
Furthermore, we found that SIP2/2 mice have smaller
thymus glands and spleens than wild-type mice as a re-
sult of reduced lymphocyte cellularity. Recently, b-cate-
nin has been implicated in T cell development. Indeed,
deletion of b-catenin, Tcf-1, or adenomatous poliposis
coli (APC) in the thymus impairs the transition from
DN3 to DN4 stage (Gounari et al., 2005; Ioannidis et al.,
2001; Xu et al., 2003). In contrast, conditional stabiliza-
tion of active b-catenin in the thymus results in escape
from the pre-TCR checkpoint and promotes thymocyte
transition from the DN3 to DN4 and then to the DP stage
in the absence of TCRb selection (Gounari et al., 2001).
However, while promoting differentiation, expression
of active b-catenin in thymocytes results in reduced cel-
lularity of the thymus, apparently as a result of apoptosis
induction (Gounari et al., 2001). SIP deficiency produces
a remarkably similar phenotype as enforced expression
of b-catenin protein in DN cells, further underlining the
essential role of b-catenin in thymocyte development.
Indeed, DN3 SIP2/2 thymocytes appeared to transit to
the DN4 stage in the absence of pre-TCR signaling,
given that SIP2/2 DN4 cells contained abnormally low
levels of TCRb. Also, like b-catenin-overexpressing
mice, the thymus glands of SIP2/2 mice have reduced
cellularity, and thymocytes undergo increased apopto-
sis in culture.
The phenotype of SIP2/2 mice is relatively modest
compared with mice in which stabilized b-catenin was
expressed or APC gene was disrupted in thymocytes
(Gounari et al., 2001, Gounari et al., 2005). As shown in
Figures 4A and 4B, levels of b-catenin in SIP2/2 DN thy-
mocytes were 3–4 times higher than in wild-type mice.
However, b-catenin-overexpressing mice and APC2/2
mice show a huge accumulation of b-catenin in thy-
mocytes (Gounari et al., 2001, Gounari et al., 2005),
suggesting that the severity of the phenotype is deter-
mined by the magnitude of b-catenin accumulation.
We would propose that the degree of b-catenin accumu-
lation seen in our SIP2/2 mice is probably more physio-
logical than the amounts observed in mice with stabi-
lized b-catenin.
In addition to b-catenin, p53 is also implicated in the
control of the pre-TCR checkpoint. Loss of p53 in pre-
TCR-deficient thymocytes promotes their survival and
differentiation in the absence of TCR gene rearrange-
ments (Bogue et al., 1996; Guidos et al., 1996; Haks
et al., 1999; Jiang et al., 1996). The fact that p53 and
SIP loss phenocopy each other in this regard suggests
a functional connection between p53 and b-catenin deg-radation in the pre-TCR checkpoint, consistent with
prior data showing that p53 induces Siah1 expression
(Fiucci et al., 2004). It has been hypothesized that dou-
ble-strand-DNA breaks during V(D)J recombination trig-
ger the p53 pathway to delay cell-cycle progression at
the G1 checkpoint (Nelson and Kastan, 1994). However,
suppression of recombinase activity was observed in
SIP2/2 DN cells, similar to observations made for mice
with stabilized b-catenin and APC2/2 mice (Gounari
et al., 2001, Gounari et al., 2005). These observations
may rather support a hypothesis that cell-cycle arrest
is required to initiate TCR gene rearrangements, with
SIP2/2 and APC2/2 thymocytes failing to arrest and
thus differentiating without TCR gene rearrangements.
Regardless of the explanation, our data show that SIP
is required to prevent maturation of thymocytes in the
absence ofTCRgene rearrangements, which is a pheno-
type observed in p53-null and APC-null mice, consistent
with prior data linking p53, APC, and SIP into a pathway
controlling b-catenin degradation (Gounari et al., 2001,
Gounari, et al., 2005).
Siah1a2/2 mice also have reduced cellularity (30%–
50% that of normal mice) of lymphoid organs, including
thymus, spleen, and lymph nodes, suggesting a role for
Siah1 in lymphoid development (Frew et al., 2004). Siah-
family proteins bind ubiquitin-conjugating enzymes
(UBCs) via an N-terminal RING domain and target other
proteins for degradation. Twenty-three potential target
proteins of Siah-mediated degradation have been re-
ported, including DCC, a putative tumor-suppressor
protein possibly involved in colon cancers (Hu et al.,
1997); N-CoR, a transcriptional corepressor that regu-
lates nuclear steroid hormone and retinoid receptors
(Zhang et al., 1998); PHD1/3, a family of prolyl-hydroxy-
lases (Nakayama et al., 2004); and the proto-oncogene
c-Myb (Tanikawa et al., 2000). Although there is no direct
evidence that SIP is involved in Siah-induced degrada-
tion of these proteins, it has been reported that c-Myb
is required for development of thymocytes at the DN3
stage, as well as for survival of DP cells and for differen-
tiation of SP cells (Bender et al., 2004; Lieu et al., 2004).
These observations thus suggest that SIP may control
stability of other proteins in addition to b-catenin.
Thus, further studies should address the role of SIP in
controlling the stability of c-Myb and other proteins
that are known targets of Siah1.
Experimental Procedures
Generation of SIP-Deficient Mice and Genotyping
Searching the Omni Bank database (http://www.lexgen.com) for ES
cell clones with retrovirus insertions in the SIP gene, we found
a clone in which the integration site for the retrovirus was located
in the first intron of mouse SIP gene. The position of retrovirus inser-
tion was determined by Southern blotting with probes derived from
exon 2 of mouse SIP gene, which was amplified by PCR methods.
Genomic DNA was isolated from MEFs of wild-type and SIP-defi-
cient littermate mice. A total of 10 mg of DNA was digested with
XbaI and size fractionated in agarose-gel electrophoresis, followed
by transfer to Hybond N+ nylon membranes. Membranes were incu-
bated with random primed 32P-labeled mouse SIP cDNA probe in
10% dextran-sulfate, 1% SDS, and 1 M NaCl solution at 68ºC for
overnight. Membranes were washed with 23 SSC, 0.1% SDS at
room temperature, followed by 13 to 0.13SSC at increased temper-
ature. Autoradiography was performed overnight at 280ºC with
Kodak AR film.
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Primary MEFs were derived from E14.5 embryos according to stan-
dard protocols (Chae et al., 2004). p532/2 MEFs were kindly pro-
vided by Dr. Inder M. Verma (The Salk Institute). Cells were cultured
at 37ºC (5% CO2) in high-glucose Dulbecco’s modified Eagle’s me-
dium (DMEM, Irvine Scientific) with 10% fetal calf serum (FCS), 1 mM
L-glutamine, and antibiotics (DMEM 10). For the experiments using
serum-starved cells, asynchronous cells at 70% confluence were
washed with phosphate-buffered saline, placed in DMEM containing
0.1% FCS (DMEM 0.1) for 96 hrs, and then trypsinized in growth me-
dium before being subjected to g irradiation. Cell were irradiated at
0 or 20 Gy and then cultured in DMEM 10.
Thymocyte Immunophenotyping
The following monoclonal antibodies (mAbs) for flow cytometry
were obtained from BD Biosciences Pharmingen: anti-CD4, anti-
CD8, anti-CD25, anti-CD44, anti-TCRb(H57-597), anti-TCRgd(GL3),
anti-DX5, and anti-B220. These mAbs were directly coupled to fluo-
rescein isothiocyanate (FITC), phycoerythrin, cyanine-dye-coupled
peridinin chlorophyll protein (PerCP-Cy5.5), or allophycocyanin.
Thymocytes were incubated with 2.4G2 (anti-CD16/32) to reduce
the background. Cells were flow sorted with a FACSCanto (BD Bio-
sciences Pharmingen), and data were analyzed with FlowJo soft-
ware (Tree Star).
Intracellular-Thymocyte Staining
Thymocytes were labeled for cell-surface markers to define DN3 and
DN4 stages. The cells were then fixed for 10 min in PBS with 2%
paraformaldehyde at room temperatur, and incubated with anti-
TCRb or anti-b-catenin-FITC (14, BD Bioscience) in PBS with 3%
FCS and 0.5% Saponin (Sigma). After washing with PBS with 3%
FCS and 0.5% Saponin, cells were sorted and analyzed.
Apoptosis Analysis
Thymocytes were suspended at a density of 13 106/ml in RPMI 1640
medium with 10% FCS, 50 mM b-mercaptoethanol, and 1 mM
L-glutamine and antibiotics. Cells were cultured at 37ºC (5% CO2)
for 24 hr and then stained for cell-surface markers to define the stage
of differentiation. Apoptotic cells were identified by Annexin V-FITC
staining (BioVision).
Histological Analysis
Tissues were dissected and fixed in zinc-buffered formalin (Z-fix,
Anatech). Paraffin sections (0.5 mm) were prepared by standard pro-
cedures and stained with hematoxylin and eosin (H&E). For immuno-
histochemistry, paraffin sections were deparaffinized by standard
procedures and then incubated with anti-Thy-1 antibody or anti-
B220 antibody (BD-Biosciences). The sections were visualized
with 3,3-Diaminobenzidine and counterstained with hematoxyline.
Cell-Cycle Analysis
Cells were pulse labeled with 10 mM BrdU (4 hr; Sigma) for asynchro-
nous cells or with 65 mM (24 hr) for synchronized cells. Labeled cells
were fixed in 70% ethanol and stored at220ºC overnight. Cells were
denatured by incubation with 2 N HCl and 0.5% Triton X-100 for
30 min at room temperature, followed by neutralization with 0.1 M
Sodium Tetraborate (pH 8.5). Cells were subjected to dual-color
staining with FITC-conjugated anti-BrdU mAb (BD Biosciences)
and 5 mg/ml propidium iodide. Cell-cycle analyses were carried
out with FACSort (Becton Dickinson) and FlowJo software (Tree
Star).
Immunoblotting
Cells were lysed with RIPA buffer (50 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 1% NP-40, 0.5% Deoxycholic acid, 0.1% SDS). Equal amounts
of cell lysates were subjected to immunoblot analysis with anti-
bodies to Cyclin D1 (DCS-6, BD Biosciences), c-Myc (N-262, Santa
Cruz), or Hsc70 (K-19, Santa Cruz). For distinguishing cytosolic
and nuclear b-catenin, cells were suspended in 50 mM MES buffer
(pH 6.8) containing 2.5 mM EGTA, 5 mM MgCl2, and 0.5% Triton
X-100 (Sadot et al., 2000). Cell extracts were then centrifuged at
12,000 3 g for 5 min, and resulting Triton X-100-soluble (cytosolic)
fractions and Triton-X-insoluble (nuclear) fractions were separated
by SDS-PAGE (12% gels) and transferred to nitrocellulose mem-branes. Proteins were detected with anti-b-catenin monoclonal
antibody (14, BD Biosciences), and blots were reprobed with anti-
bodies to a-tubulin (TU-01, Zymed Laboratories) and PARP (C2-
10, BD Biosciences).
Retroviral-Infection GFP Reporter Assay
The retroviral 12/23 rEGFP vector was kindly provided by Dr. Cortez
(Mt. Sinai School of Medicine). The vector contains a reverse EGFP
reporter (rEGFP) between 12 and 23 RSS. For retroviral infection,
293T cells at 60%–70% confluence were transfected with 5 mg
pMD.G (encodes vesicular stomatitis G Protein), 8 mg pMD.OGP (en-
codes gag-pol), and 10 mg retroviral 12/23 rEGFP vector for 48 hr.
Thymocytes from SIP+/+ and SIP2/2 mice were infected with retro-
viral supernatant containing 50 mM b-mercaptoethanol and 4 mg/ml
polybrene (Sigma) at 1 3 106 cells/ml in 24-well plates. For increas-
ing infection efficiency, plates were centrifuged with a swing-bucket
rotor at 1400 3 g, 30ºC for 60 min. After 48 hr infection at 37ºC/5%
CO2, cells were harvested and analyzed by flow cytometry.
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